2017
DOI: 10.1016/j.ijrobp.2017.06.1552
|View full text |Cite
|
Sign up to set email alerts
|

Treatments Received By and Timeliness of Treatment for African American and Caucasian Pancreatic Cancer Patients Across the US

Abstract: systemic therapy and/or surgery with RT. Furthermore, industry-supported trials are less likely to have RO leadership. These data suggest a need for RO to advocate for greater leadership in multi-modality trials, NIH-support, and collaboration with industry.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles